GRAVITY ANNOUNCES FILING OF ANNUAL REPORT ON FORM 20-F FOR FISCAL YEAR 2019
Seoul, April 29, 2020 (GLOBE NEWSWIRE) — GRAVITY Co., Ltd. (NasdaqGM: GRVY) (“Gravity” or the “Company”) today announced that the […]
uniQure Announces First Quarter 2020 Financial Results and Highlights Recent Company Progress
~ Completed Target Patient Dosing in Phase III HOPE-B Trial of Etranacogene Dezaparvovec in Hemophilia B ~~ Announced 22 Presentations […]
resTORbio and Adicet Bio Announce Merger Agreement to Advance Allogeneic Gamma Delta CAR-T Cell Therapy Technology
Combined Company to Focus on Adicet’s Technology and Continue Operations as “Adicet Bio”Adicet’s lead asset ADI-001 is an allogeneic gamma […]
Plug Power to Announce 2020 First Quarter Results
LATHAM, N.Y., April 29, 2020 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ:PLUG), a leading provider of zero emission hydrogen engines […]
Chimerix Announces Initiation of a Phase 2/3 Study of DSTAT in Acute Lung Injury for Patients with Severe COVID-19
FDA Clearance to Proceed with Phase 2/3 Randomized, Double-Blind, Placebo Controlled StudyMechanisms of Action May Address Overactive Inflammatory Response, Including […]
G1 Therapeutics to Provide First Quarter 2020 Corporate and Financial Update on May 6, 2020
RESEARCH TRIANGLE PARK, N.C., April 29, 2020 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today […]
HOOKIPA Pharma to Present at Upcoming Conferences in May
NEW YORK and VIENNA, Austria, April 29, 2020 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing […]
ADMA Biologics to Report First Quarter 2020 Financial Results on May 6, 2020
RAMSEY, N.J. and BOCA RATON, Fla., April 29, 2020 (GLOBE NEWSWIRE) — ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA”), an end-to-end […]
MarketAxess Reports First Quarter 2020 Record Revenues of $169.0 Million, Record Operating Income of $91.1 Million and Record Diluted EPS of $1.96
First Quarter Financial Highlights*Record revenues of $169.0 million, up 36%Record operating income of $91.1 million, up 44%Operating margin of 53.9%, […]
BrainStorm-Cell Therapeutics to Announce First Quarter Financial Results and Provide a Corporate Update
NEW YORK, April 29, 2020 (GLOBE NEWSWIRE) — BrainStorm-Cell Therapeutics Inc. (NASDAQ: BCLI), a leader in developing innovative autologous cellular therapies […]
